Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Layton

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Gene Therapy|March 23, 2018
Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinomaBijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 2, 2013
Transition to a novel advanced integrated vitrectomy platform: comparison of the surgical impact of moving from the Accurus vitrectomy platform to the Constellation Vision System for microincisional vitrectomy surgeryTimothy G Murray, Andrew J Layton, Kuo B Tong, et al.
Archives of Dermatology|April 22, 2009
Factors associated with physician discovery of early melanoma in middle-aged and older menAlan C Geller, Timothy M Johnson, Donald R Miller, et al.
Gene Therapy|April 10, 2019
Adeno-associated virus neutralising antibodies in type 1 diabetes mellitusSlawomir Andrzejewski, Aparna Murali, Charmaine Ramlogan-Steel, et al.
Archives of Dermatology|April 22, 2009
Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spousesSusan M Swetter, Christle J Layton, Timothy M Johnson, et al.
Archives of Dermatology|April 22, 2009
Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thicknessSusan M Swetter, Timothy M Johnson, Donald R Miller, et al.
The Journal of Biological Chemistry|April 23, 1999
Intermolecular interactions of the p85alpha regulatory subunit of phosphatidylinositol 3-kinaseA G Harpur, M J Layton, P Das, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 25, 2026
Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational OpportunitiesRebecca J Wilson, Charmaine A Ramlogan-Steel, William J Deasy, et al.
The EMBO Journal|September 1, 1993
Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinantC M Owczarek, M J Layton, D Metcalf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Gene Therapy|March 23, 2018
Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinomaBijay Dhungel, Slawomir Andrzejewski, Aparna Jayachandran, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 2, 2013
Transition to a novel advanced integrated vitrectomy platform: comparison of the surgical impact of moving from the Accurus vitrectomy platform to the Constellation Vision System for microincisional vitrectomy surgeryTimothy G Murray, Andrew J Layton, Kuo B Tong, et al.
Archives of Dermatology|April 22, 2009
Factors associated with physician discovery of early melanoma in middle-aged and older menAlan C Geller, Timothy M Johnson, Donald R Miller, et al.
Gene Therapy|April 10, 2019
Adeno-associated virus neutralising antibodies in type 1 diabetes mellitusSlawomir Andrzejewski, Aparna Murali, Charmaine Ramlogan-Steel, et al.
Archives of Dermatology|April 22, 2009
Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spousesSusan M Swetter, Christle J Layton, Timothy M Johnson, et al.
Archives of Dermatology|April 22, 2009
Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thicknessSusan M Swetter, Timothy M Johnson, Donald R Miller, et al.
The Journal of Biological Chemistry|April 23, 1999
Intermolecular interactions of the p85alpha regulatory subunit of phosphatidylinositol 3-kinaseA G Harpur, M J Layton, P Das, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 25, 2026
Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational OpportunitiesRebecca J Wilson, Charmaine A Ramlogan-Steel, William J Deasy, et al.
The EMBO Journal|September 1, 1993
Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinantC M Owczarek, M J Layton, D Metcalf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatmentS Glück, A A Ross, T J Layton, et al.
Pageof 20